Identifier: TFG:890
Authors: Bermejo Rodríguez, Marta; Caro Rodríguez, Paula; Martínez Madurell, Mar; Pla Pagà, Laura
Abstract:
Introduction: Cardiovascular disease is the first cause of morbidity and mortality in the world. There are different risk factors that influence the appearance of this disease such as: hypertension, dyslipidemia, obesity, type 2 diabetes, sedentary lifestyle and following an unhealthy diet. One of the tools to prevent or fight cardiovascular disease is bioactive compounds. Linseed can improve blood pressure (BP), lipid profile and glucose plasmatic levels thanks to its characteristics, and its content of soluble fiber, lignan and alfa-linoleic acid. The aim of this systematic review is to evaluate the effects of linseed consumption on different cardiovascular risk factors. Method: The information was obtained from data bases Pubmed, Cochrane Plus and Scopus, following the criteria of declaration PRISMA. This review has included studies published in the last 5 years, in english, performed in humans, interventional or observation-based studies and performed in all kinds of populations, ethnicity and age that had at least one of the following cardiovascular risk factors: elevated BP, type 2 diabetes, dyslipidemia, obesity or hyperuricemia. Results: A consumption of 30 daily grams of linseed or more in a period between 4 and 12 weeks decreases systolic BP 1,20-12,00 mm Hg and diastolic BP 2,32-7,77 mm Hg, and improve the lipid profile, either in form of a supplement of the seeds or incorporated in food, in people with elevated BP and/or dyslipidemia. On the other hand, it hasn’t been observed any effects in the consumption of daily linseed on glucose metabolism, obesity and uric acid levels. Conclusions: Daily consumption of linseed between 30 and 60 g could help improve BP and lipid profile in pre-hypertensive or hypertensive subjects and those with dyslipidemia. Even so, more well-designed interventional studies are needed to confirm those results. Keywords: linseed, CVRF
Repositori URV